Christer Bergquist

No ORCID on file · 11 papers in corpus · active 1984-2005

Study types

  • article 11

Condition tags

  • endometriosis 8
  • infertility 2
  • mesh:D004716 1
article 2005
Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy
·doi:10.1080/j.0001-6349.2005.00658.x

Background. Retrospective studies have indicated differences in sexuality and general psychological well-being between women who have undergone hysterectomy only and those undergoing hysterectomy and oophorectomy. These differences may be t…

article 2005
Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being
·doi:10.1016/j.fertnstert.2004.12.008
article 2004
Prophylactic oophorectomy at elective hysterectomy
·doi:10.1016/j.maturitas.2004.08.018
article 2000
[Current aspects on the treatment of endometriosis].
Lakartidningen

The aim of pharmacological treatment of endometriosis is to reduce estrogen levels, which may be achieved using gestagens or GnRH-agonists. The effects of the different hormones are mainly the same, while side effects differ. If the GnRH-ag…

article 2000
[Endometriosis--an inflammatory disease in women. Pain and reduced fertility are serious symptoms].
Lakartidningen

Endometriosis is a common disease with serious consequences for the patient and for society. Until now there has been no reliable method for diagnosing endometriosis besides direct visualization, e.g. utilizing laparoscopy. IVF offers the m…

article 1997
Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(97)70084-x

ObjectiveOur goal was to determine the effects of a repeated course of the gonadotropin-releasing hormone agonist nafarelin on symptoms and signs of endometriosis and lumbar and distal radius bone mineral density.Study designForty-five wome…

article 1992
Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up
·doi:10.1016/0020-7292(92)90702-k
article 1991
[Endometriosis and infertility].
Lakartidningen
article 1990
Effects of nafarelin versus danazol on lipids and calcium metabolism
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(90)90438-d

This 6-month clinical trial with an additional 12-month follow-up compared the effects of treatment with the gonadotropin-releasing hormone agonist nafarelin and the androgenic agent danazol on lipids and calcium metabolism in women with en…

article 1989
Clinical experience treating endometriosis with nafarelin.
The Journal of reproductive medicine

The preliminary results from an ongoing multicenter trial further support the efficacy and excellent tolerability of nafarelin in the management of endometriosis.

article 1984
A New Superagonist of GnRH for Inhibition of Ovulation in Women
Upsala journal of medical sciences ·doi:10.3109/03009738409178474

This paper presents the initial results from a study that used a new superagonist of gonadotrophin-releasing hormone (GnRH), naferelin acetate, for the inhibition of ovulation. The superagonist was administered by nasal spray daily for 12 w…